Oncology Collaboration and Licensing Deals 2020-2025

Oncology Collaboration and Licensing Deals provides the reader with the following key benefits:

• Understand deal trends since 2020
• Browse oncology collaboration and licensing deals
• Benchmark analysis – identify market value of transactions
• Financials terms - upfront, milestone, royalties
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Executive Summary

 

Chapter 1 – Introduction

 

Chapter 2 – Trends in oncology dealmaking

 

2.1. Introduction

2.2. Oncology partnering over the years     

2.3. Oncology partnering by deal type

2.4. Oncology partnering by industry sector

2.5. Oncology partnering by stage of development

2.6. Oncology partnering by technology type

2.7. Oncology partnering by therapeutic indication

 

Chapter 3 – Financial deal terms for oncology partnering

 

3.1. Introduction

3.2. Disclosed financials terms for oncology partnering

3.3. Oncology partnering headline values

3.4. Oncology deal upfront payments

3.5. Oncology deal milestone payments

3.6. Oncology royalty rates

 

Chapter 4 – Leading oncology deals and dealmakers

 

4.1. Introduction

4.2. Most active in oncology partnering

4.3. List of most active dealmakers in oncology    

4.4. Top oncology deals by value

 

Chapter 5 – Oncology contract document directory

                                            

5.1. Introduction

5.2. Oncology partnering deals where contract document available

 

Chapter 6 – Oncology dealmaking by therapeutic target

 

6.1. Introduction

6.2. Deals by oncology therapeutic target

 

Deal directory

 

Deal directory – Oncology deals by company A-Z 2020 to 2025

Deal directory – Oncology deals by technology type 2020 to 2025

 

Deal type definitions

 

About Biopharma Research Ltd

 

Current Partnering

Current Agreements

Recent report titles from Current Partnering

 

Table of figures

 

Figure 1: Oncology partnering since 2020

Figure 2: Oncology partnering by deal type since 2020

Figure 3: Oncology partnering by industry sector since 2020

Figure 4: Oncology partnering by stage of development since 2020

Figure 5: Oncology partnering by technology type since 2020

Figure 6: Oncology partnering by indication since 2020

Figure 7: Oncology deals with a headline value

Figure 8: Oncology deals with upfront payment values

Figure 9: Oncology deals with milestone payment

Figure 10: Oncology deals with royalty rates

Figure 11: Active oncology dealmaking activity since 2020

Figure 12: Top oncology deals by value since 2020

Pricing options

• $4,995: single-user (encrypted file - one user/device)
• $6,995: multi-user (encrypted file - up to 5 users/devices)
• $7,995: company (unencrypted file)

Single and Multi-user license files are encrypted PDF documents. Details of how to access using Javelin3 PDF Reader will be provided at report delivery.

Company license files are not encrypted and can be accessed using a PDF Reader.

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

All card payments are processed by Evalon.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

1ST Biotherapeutics, 2cureX, 2seventy bio, 3B Pharmaceuticals, 3D Medicines, 3SBio, 3T Biosciences, 4baseCare, 4bases, 4C Biomed, 4D Path, 4D Pharma, 7 Hills Pharma, 9 Meters Biopharma, 48Hour Discovery, 111, A*STAR Agency for Science, Technology and Research, A*STAR Bioprocessing Technology Institute, A*STAR Singapore Immunology Network, A*STAR’ Institute of Molecular and Cell Biology, A2 Biotherapeutics, A2A Pharmaceuticals, A3P Biomedical, Aadi Bioscience, Aarvik Therapeutics, Abbisko Therapeutics, Abbott Laboratories, Abbvie, Abcam, AbCellera Biologics, Abdul Latif Jameel Health, AbelZeta Pharma, Abera Bioscience, Abilita Bio, Abilita Therapeutics, Abintus Bio, Abiosciences, Ablaze Pharmaceuticals, ABL Bio, Ab Magnitude Ventures, Abound Bio, Abpro, Abramson Cancer Center, AbSci, AbTherx, AbTis, ABVC BioPharma, Abveris, ABX, Academic Breast Cancer Consortium, Accelerated Biosciences, Accent Therapeutics, Access to Comprehensive Genomic Profiling Coalition, Acclinate, Accuray, AccuStem Sciences, ACEA Therapeutics, Acepodia, Acerand Therapeutics, Acerta Pharma, Achilles Therapeutics, Acibadem University, Acrivon Therapeutics, Acrotech Biopharma, Actimed Therapeutics, Actinium Pharmaceuticals, ACT Therapeutics, Actuate Therapeutics, Acucela, Acuitas Therapeutics, Adagene, AdAlta, Adamis Pharmaceuticals, Adaptimmune, Adaptive Biotechnologies, Adaptive Research, AdaptVac, Adcendo, ADC Therapeutics, Addario Lung Cancer Medical Institute, AdhereTech, Adimab, Adlai Nortye, Advancell, Advaxis, Advenchen Laboratories, Aerogen, Aethlon Medical, Aethon Therapeutics, Aetion, Affimed Therapeutics, Affini-T Therapeutics, AGC Biologics, Agena Bioscience, Agencja Badan Medycznych, Agendia, Agenus Bio, AgeX Therapeutics, Agilent Technologies, Agios Pharmaceuticals, AgonOx, AiCure, Aidence, Aidoc, Aignostics, AIkido Pharma, AI Longevity, AimedBio, AIM ImmunoTech, Ainos, Aion Therapeutic, AI Proteins, Aitia, AiVita Biomedical, Ajax Therapeutics, Ajinomoto, Akamis Bio, Akeso Biopharma, Akoya Biosciences, AKSO Biopharmaceutical, Akston Biosciences, Aktis Oncology, Alamar Biosciences, Alaya.bio, Albany Medical College, Alberta Health Services, Albert Einstein College of Medicine, Alcedis, Alchemab, Alector, Alessa Therapeutics, Aleta Biotherapeutics, Alex’s Lemonade Stand Foundation, Alibaba Health, ALK Positive, Alkyon Therapeutics, All4Cure, Allarity Therapeutics, Allcyte, Allelica, Alliance for Cancer Gene Therapy, Alliance Foundation Trials, Alligator Bioscience, Allist Pharma, Allogene Overland Biopharm, Allogene Therapeutics, Alloplex Biotherapeutics, Allorion Therapeutics, Alloy Therapeutics, Almac Diagnostics, Almac Group, Almirall, Alopexx, Alpha Biopharma, Alpha Cancer Technologies, Alphageneron Pharmaceuticals, Alphamab Biopharmaceuticals, Alphamab Oncology, Alpha Tau Medical, Alpine Immune Sciences, Alteogen, Alverno Clinical Laboratories, Alvotech, ALX Oncology, Amasa Therapeutics, Amazon Web Services, Amber Pharmacy, Ambry Genetics, American Association for Cancer Research, American Lung Association, American Preclinical Services, American Skin Association, American Society of Clinical Oncology (ASCO), American Type Culture Collection (ATCC), Amgen, AmMax Bio, Amneal Pharmaceuticals, Amoy Diagnostics, Amphista Therapeutics, AmplifyBio, Amunix, AnchorDx, Angiogenesis Foundation, Angle, AnHeart Therapeutics, Anima Biotech, Anivive Lifesciences, Anixa Biosciences, Anji Pharma, Anju Software, Ankarys Therapeutics, Ankyra Therapeutics, Anocca AB, Anova Enterprises, Anpac Bio-Medical Science, ANP Technologies, Antengene, Anthony Nolan, Antisoma Therapeutics, Antiverse, Apeiron Biologics, Apexigen, Apmonia Therapeutics, Apollomics, Apollon Formularies, Apollo Therapeutics, Appia Bio, Applied BioMath, Applied Biomedical Science Institute, Applied Cells, Applied DNA Sciences, Applied StemCell, AppliedVR, Aprea Therapeutics, Apricity Health, Aptevo Therapeutics, Aptorum Group, Aptose Biosciences, Aqemia, Araris Biotech, ARase Therapeutics, Aravive Biologics, Arbor Biotechnologies, Arcellx, ArcherDX, Arch Oncology, ARC Therapeutics, Arctoris, Arcturus Therapeutics, Arcus Biosciences, Ardeagen, Arecor, argenx, Ariceum Therapeutics, Arizona State University, Arovella Therapeutics, Arrayus Technologies, ArriVent Biopharma, Arsenal Biosciences, ARTBIO, Artelo Biosciences, ArteraAI, Arthrosi Therapeutics, Artidis, Artios Pharma, Artiva Biotherapeutics, Artizan Biosciences, ARTMS Product, Arvinas, Asan Medical Center, Ascentage Pharma, Asher Bio, Asher Biotherapeutics, Ashion Analytics, Asieris MediTech, Asieris Pharmaceuticals, AskGene Pharma, Assistance Publique-Hôpitaux de Paris, Astellas Pharma, Astellas Pharma US, Astex Pharmaceuticals, AstraZeneca, Astrea Bioseparations, Astrin Biosciences, Asylia Therapeutics, Asymchem Laboratories, Atara Biotherapeutics, Athebio, Athenex, Atlas Antibodies, ATP, Atreca, Atrin Pharmaceuticals, AUM Biosciences, Aurelius Biotherapeutics, Aurigene Discovery Technologies, Australian and New Zealand Children’s Haematology / Oncology Group, Australian Nuclear Science and Technology Organisation, Australian Research Data Commons, Autolus, Autonomous Therapeutics, Autotelic BIO, Avacta, Avatamed, Avectas, Avenzo Therapeutics, AVEO Oncology, Avera Health, Aviceda Therapeutics, Avicenna Biosciences, Aviko Radiopharmaceuticals, AVM Biotechnology, Avrobio, Axcelead Drug Discovery Partners, Axis Therapeutics, Azos Bio, Azra AI, Bach Biosciences, Baili Biopharmaceutical, BAKX Therapeutics, BAMF Health, Banner MD Anderson Cancer Center, Barbara Ann Karmanos Cancer Institute, Barer Institute, Barrow Neurological Institute, Basilea Pharmaceutica, Bayer, Baylor College of Medicine, Baylor Scott and White Research Institute, BC Cancer Agency, BC Platforms, B dot Medical, Beactica, Beam Therapeutics, Beartooth Therapeutics, Bebig, Be Biopharma, BEC, Becton Dickinson, BeiGene, Beijing Genomics Institute (BGI), Beijing InnoCare Pharma, Beijing Tide Pharmaceutical, Beijing Xisike Clinical Oncology Research Foundation, Belharra Therapeutics, Bellicum Pharmaceuticals, BenevolentAI, Bennu Pharmaceuticals, BerGenBio, Beroni Group, Berry Oncology, Best Medical International, Be The Match BioTherapies, Beth Israel Deaconess Medical Center, Bethyl Laboratories, Betta Pharmaceuticals, Beverly Hills Cancer Center, Beyond Cancer, Beyondspring Pharmaceuticals, BGN Technologies, Bicycle Therapeutics, BigHat Biosciences, Binghamton University, BinnoPharm, Bio-Manguinhos/Fiocruz, Bio-Rad Laboratories, Bio-Techne, Bio-Thera Solutions, bioAffinity Technologies, BioAgilytix, Bioarchitech, BioArdis, biOasis Technologies, BioAtla, Biobot Surgical, Biocare Medical, Biocartis, Biocept, BioCheetah, BioCina, BioCity Biopharma, Biocodices, Biocon, BioCopy, BiocurePharm, Biocytogen, Biodesix, BioDuro, BioEclipse Therapeutics, BioEleven, BioElpida, Biofidelity, Biogenar, Biognosys, Biohaven Pharmaceuticals, BioIntelliSense, BioInvent, BioKey, BiolineRX, Biological Dynamics, Biolojic Design, BioMark Diagnostics, Biomarker Collaborative, BioMarker Strategies, Biomedical Advanced Research and Development Authority, Biomedical Catalyst Fund (UK), Biomedical Primate Research Centre, BioMed Valley Discoveries, BioMed X Innovation Center, Biomica, Biomm, Biomunex Pharmaceuticals, BioNano Genomics, Bionaut Labs, Biond Biologics, BiOneCure Therapeutics, Bionetix, BioNex Solutions, Bioniz Therapeutics, Bionomics, BioNova Pharmaceuticals, BioNTech, Biortus Biosciences, Biosceptre International, Biose Industrie, BioSenic, BioSight, Biosion, Biositu Pharmaceutical Technology, BioSkryb, Biosplice, BioStrand, BioTheryX, Biotheus, BioVaxys, BioVectra, Bioventure MDC, BioVolume, Bird Foundation, bitBiome, Bixink Therapeutics, BJ Bioscience, Black Diamond Therapeutics, Blackford, Blacksmith Medicines, Blackstone, Blau Pharma, Bliss Biopharmaceutical, Blood Centers of America, Blu Biotech, Bluebird Bio, Bluebridge Technologies, Blue Earth Diagnostics, Blue Note Therapeutics, Blueprint Medicines, Boehringer Ingelheim, Bold Therapeutics, Bolt Biotherapeutics, Bon Secours Health System, Boostimmune, Boryung Pharmaceutical, BostonGene, Boston Immune Technologies and Therapeutics, Boston Pharmaceuticals, Boston University, Bot Image, Boundless Bio, BPGbio, Bpifrance, Bracco Imaging, BRAIN Biotech, Brainomix, Brazlex Medical Genetics, Breakthrough Genomics, Brenus Pharma, BriaCell Therapeutics, BridgeBio Pharma, Bridge Biotherapeutics, Bridge Medicines, BridGene Biosciences, Brigham and Women's Hospital, BrighGene Biomedical, BrightPath Biotherapeutics, Bright Peak Therapeutics, Brii Biosciences, Bristol-Myers Squibb, Broad Institute, Brooklyn ImmunoTherapeutics, Brown University, BryoLogyx, Bugworks, Burning Rock, Busan Paik Hospital, BWXT Medical, BYOMass, Byondis, C-RAD, C2i Genomics, C4 Therapeutics, Calian Group, Calico, Calidi Biotherapeutics, Califia Pharma, California Institute for Regenerative Medicine, Calithera Biosciences, Calviri, Calyx, Cambridge Cancer Genomics, Cambridge Quantum Computing, Can-Fite BioPharma, Canadian Cancer Society, Canadian Institutes of Health Research, Canadian Nuclear Laboratories, CanariaBio, Cancer and Blood Specialty Clinic, CancerCare, Cancer Focus Fund, Cancer Genetics, Cancer Hospital Chinese Academy of Medical Sciences, Cancer Prevention and Research Institute of Texas, Cancer Research Horizons, Cancer Research UK, Cancer Science Institute of Singapore, CancerVax, CancerX initiative, Candel Therapeutics, Cannabics Pharmaceuticals, Cannomed Medical Cannabis Industries, CanProbe, Cantargia, Cantex Pharmaceuticals, Capsulomics, Caravan Biologix, Cardiff Oncology, Cardiff University, CARE, Care Access Research, Caribou Biosciences, Carina Biotech, Caring Cross, Caris Life Sciences, Carisma Therapeutics, Carna BioSciences, Carnegie Mellon University, Carrick Therapeutics, CARsgen, Cartexell, CARTI Cancer Center, Cartography Biosciences, Case Western Reserve University, CASI Pharmaceuticals, Castle Biosciences, Catalent, Catamaran Bio, Catholic University Leuven, Ceapro, Cedars-Sinai Medical Center, Cedilla Therapeutics, CeGaT, Celanese, Celcuity, Celest Therapeutics, Cell&Soft, Cell-Easy, Cellares, Cellaria Biosciences, CellBion, CellCarta, Cellect Biotechnology, Cellectis, Cellenkos, Cellerant Therapeutics, Cellevolve Bio, Cellipont Bioservices, Cellistic, Cellkey, CellMax Life, Cell Mogrify, CellOrigin Biotech, Cellpath, Cell Point, Cell Therapy Manufacturing Center, Celltrion, Cellular Biomedicine, Cellworks, Celsius Therapeutics, Celularity, Cencora, Cend Therapeutics, Centene, Center for Biomarker Research in Medicine, Centre for Clinical Cancer Research, Centre for Commercialization of Cancer Immunotherapy and Regenerative Medicine, Centre for Commercialization of Regenerative Medicine (CCRM), Centre for Imaging Technology Commercialization, Centre for Probe Development and Commercialization, Centre Hospitalier Universitaire Vaudois (CHUV), Centre Leon Berard, Century Therapeutics, Cepheid, Cerecor, Cerner, CERo Therapeutics, Certara, Certis Oncology Solutions, Cevec Pharmaceuticals, CG Oncology, Champalimaud Foundation, Champions Oncology, CHAMPS Oncology, Changchun High & New Technology Industries, Chao Center, Charite Universitatsmedizin Berlin, Charles River Laboratories, Checkmate Pharmaceuticals, Checkpoint Therapeutics, Chemify, Chemveda Life Sciences, Chengdu Baiyu Pharmaceutical, Chi-Med, Children's Hospital at Montefiore, Children's Hospital Boston, Children's Hospital Los Angeles, Children's Hospital of Philadelphia, Children's National Hospital, Children's Tumor Foundation, Children´s Oncology Group (COG), Children’s Hospital & Research Center Oakland, Chime Biologics, Chimeric Therapeutics, China Grand Pharma, China Grand Pharmaceutical, China Resources Sanjiu Medical and Pharmaceutical, Chinese University of Hong Kong, Chinook Therapeutics, Chiome Bioscience, Chipscreen NewWay Biosciences, Chong Kun Dang, Chonnam National University, CHO Plus, ChromaCode, Chronix Biomedical, Chugai Pharmaceutical, CicloMed, Cidara Therapeutics, CiMaas, Cimeio Therapeutics, Cincinnati Children’s Hospital Medical Center, Circio, Circle Pharma, Citius Pharmaceuticals, City of Hope, Cizzle Biotech, CK Life Sciences, Clarity Pharmaceuticals, Clarix, Clarus Therapeutics, Clavius Pharmaceuticals, ClearNote Health, Cleave Therapeutics, Cleveland Clinic, Cleveland University Hospitals, Clinical Laserthermia Systems (CLS), Clinical Research Data Sharing Alliance, Clinica Universidad Navarra, Clinigen, Clintrex Research, Clover Biopharmaceuticals, Clovis Oncology, CMAB Biopharma, Cmed, CMG Pharmaceutical, CMS Medical, CNAO Foundation, CNS Pharmaceuticals, Code Ocean, Coeptis Pharmaceuticals, Coeptis Therapeutics, Cofactor Genomics, Cogia Biotech, Cognizant, Coherus Biosciences, CoImmune, Collaborations Pharmaceuticals, Colorado Melanoma Foundation, Columbia University, Columbia University Medical Center, CombiGene, Combined Therapeutics, Combotope Therapeutics, Community Clinical Oncology Research Network, Compass Therapeutics, Complete Genomics, Complix, Compugen, ConcertAI, Concord Medical Services Holdings, Concr, Congenica, Congruence Therapeutics, Connect, Context Therapeutics, Convergent Bioscience, Convergent Therapeutics, Corbus Pharmaceuticals, Core Biotherapeutics, CorePath Laboratories, CorePlus, Cornell University, Cortex Design, Cortice Biosciences, Cosmos, Cosylab, COTA, Covant Therapeutics, Coya Therapeutics, Creative Biolabs, Crescendo Biologics, Crinetics, CRISPR Therapeutics, Criterium, Cromos Pharma, Crosscope, Crown Bioscience, CRT Pioneer Fund, CryoPort, CSEM Centre Suisse d'Electronique et de Microtechnique, CSPC Megalith Biopharmaceutical, CSPC Pharmaceutical Group, CStone Pharmaceuticals, CtM Biotech, CTMC, CTTQ-Akeso Biomed, Cue Biopharma, Cullgen, Cullinan MICA, Cullinan Oncology, Culmination Bio, Cumberland Pharmaceuticals, Curadh MTR, Curadigm, Curasight, Curative Biotechnology, Curebase, CureMatch, CureMD, CureMetrix, CURE Pharmaceutical, CureScience, CureVac, Curiox Biosystems, Curis, Curium, Curon Biopharmaceutical, Curta, Curtana Pharmaceuticals, CvergenX, Cybrexa Therapeutics, Cyclenium Pharma, Cyclica, CYduct Diagnostics, Cypre, Cytea Bio, Cytecare Cancer Hospitals, Cytocom, Cytodyn, CytoImmune Therapeutics, CytoLynx Therapeutics, CytoMed Therapeutics, CytomX Therapeutics, CytoReason, CytoSite Bio, Cytovation, CYTOVIA Therapeutics, DAAN Biotherapeutics, DAAN Bio Therapeutics, Daewoong Pharmaceutical, Daiichi Sankyo, Dana-Farber Cancer Institute, Dana Farber Partners Cancer Care, Danaher, Danish Cancer Society Research Center, Dante Labs, Danuo Science Group, Dartmouth College, DarwinHealth, Datavant, Day One Biopharmaceuticals, Debiopharm, Dechra Pharmaceuticals, Deciphera Pharmaceuticals, Deep Bio, Deepcell, Deep Lens, Deerfield Management, Defence Therapeutics, Deimos Biosciences, Delfi Diagnostics, Delphi Diagnostics, DeMelle OncoPharma, Denovium, Denovo Biopharma, Densitas, Department of Defense, Derm-Biome Pharmaceuticals, Detect-Ion, DeuteRx, Deverra Therapeutics, Dewpoint Therapeutics, DiaCarta, Diaccurate, Diakonos Oncology, Dialectic Therapeutics, DIAN Diagnostics, Diannei Biotechnology, Diaprost, Diatech Pharmacogenetics, DisperSol Technologies, Diverse Biotech, Dizal Pharmaceutical, DKSH, DNAnexus, DNX Biopharmaceuticals, Dolbey, DoMore Diagnostics, Dong-A Pharmaceutical, DotBio, Dr. Reddy's Laboratories, Dragonfly Therapeutics, Dragon Sail Pharmaceutical, Dren Bio, Drexel University, DualityBio, DuChemBio, Duke University, Duke University Health System, DuPont, Dxcover, DxVx, Dynavax Technologies, DYNEX Technologies, Dyve Biosciences, Eagle Pharmaceuticals, Early is Good, Eberhard Karls University Tubingen, EchelonDx, Eckert & Ziegler, Eczacibasi Pharmaceuticals, EdiGene, Edison Oncology, Editas Medicine, Edith Wolfson Medical Center, EDX Medical, eFFECTOR Therapeutics, Egle Therapeutics, Eikon Therapeutics, Eilean Therapeutics, EirGenix, Eisai, Eisana, Elekta, Elektrofi, Element Biosciences, Elephas, Elevar Therapeutics, ElevateBio, Elevation Oncology, ELIAS Animal Health, Elicio Therapeutics, Eli Lilly, Elligo Health Research, Ellipses Pharma, Elpiscience, Elthera, Embolx, EmendoBio, Emercell, Emergence Therapeutics, EmeritusDX, Emit Imaging, Emmaus Life Sciences, Emory University, Empyrean Medical Systems, Enara Bio, Endeavor BioMedicines, Endevica Bio, Endoluxe, Energenx Medical, EnGeneIC, Engimmune Therapeutics, Enlivex, Enosi Therapeutics, ENPICOM, Ensem Therapeutics, Ensysce Biosciences, Enterprise Ireland, Enveric Biosciences, Envisagenics, Enzolytics, EOC Pharma, Epic, EpicentRx, Epic Sciences, EpimAb Biotherapeutics, Epiphany Dermatology, Epitopea, EpiVax Therapeutics, Epizyme, Epsilogen, EQRx, Erasca, Erasmus University Medical Center, ERS Genomics, Ervaxx, ErVimmune, Escugen, Esperovax, ESSA Pharma, Essen University Hospital, Esteve, Eterna Therapeutics, eTheRNA immunotherapies, Eucure Biopharma, Euformatics, Euratom, Eureka Eurostars, Eureka Therapeutics, Eurobio Scientific, Eurofins Discovery, European Innovation Council, European Institute of Oncology (EIO), European Laboratory for Particle Physics, European Organization for Research and Treatment of Cancer, Eutilogics, Evariste, Evaxion Biotech, Evercyte, Everest Medicines, Evergreen Theragnostics, Eversana, EVerZom, Evive Biotechnology, Evolent Health, EvolveImmune Therapeutics, Evonik Industries, Evopoint Biosciences, EVOQ Therapeutics, Evotec, EVQLV, Ewopharma, Exacis Biotherapeutics, Exact Sciences, Exai Bio, Excellmab, ExCellThera, Excelra, Exelixis, Exigent Research, EXINI Diagnostics, ExonanoRNA, EXoPERT, Exopharm, Experimental Drug Development Centre, Expert Systems Inc, ExpreS2ion Biotechnologies, Exscientia, Exuma Biotech, Eyam Vaccines and Immunotherapeutics, F-Star Therapeutics, Factor Bioscience, Factorial Diagnostics, Falco, Family Reach, Fannin, Faraday Pharmaceuticals, Farcast Biosciences, Fate Therapeutics, FatiAbGen, Federation Bio, Fennec Pharmaceuticals, Ferronova, Ferrum Health, Fibrogen, Fidelis Research, Fight Colorectal Cancer, FineImmune Biotechnology, FivepHusion, Five Prime Therapeutics, Flagship Biosciences, Flagship Pioneering, Flame Biosciences, Flamingo Therapeutics, Flare Therapeutics, Flatiron Health, Florida Atlantic University Research, Florida Theranostics, Focal Healthcare, Foghorn Therapeutics, FogPharma, Follicular Lymphoma Foundation, Food and Drug Administration (FDA), ForDoz Pharma, Foreseen Biotechnology, Foresee Pharmaceuticals, Foresight Diagnostics, Foresite Capital, FORMA Therapeutics, Formosa Pharmaceuticals, Fortis Therapeutics, FortySix Venture Capital, FORUS Therapeutics, Fosun Pharmaceutical, Foundation Medicine, Fox Chase Cancer Center, Frame Cancer Therapeutics, Francis Crick Institute, Fred Hutchinson Cancer Research Center, Freenome, Friends of Cancer Research, Fujifilm medical systems, Fulgent Genetics, Fulgent Pharma, Full-Life Technologies, Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Fuse Oncology, Fusion Pharmaceuticals, Future Fields, FutureGen Biopharm, Fuzionaire Diagnostics, G1 Therapeutics, G42 Healthcare, Gabriella Miller Kids First Data Resource Center, Gadeta, Gaeta Therapeutics, Gain Therapeutics, Galapagos, Galecto, Galvanize Therapeutics, Gamida Cell, GANZIMMUN Diagnostics, Gastro-Intestinal Research Foundation, GATC Health, Gateway for Cancer Research, GC, GC Cell, GC Genome, GE Healthcare, GEICAM, Geisinger Health System, Gemelli Teaching Hospital, GEMoaB, GEn1E Lifesciences, GeneCentric Therapeutics, GeneCraft, GeneData, Genelux, Genentech, GeneQuantum Healthcare, General Inception, Generate Biomedicines, Generex Biotechnology, Geneseeq, GenesisCare, Genesis Research and Development, Genesis Therapeutics, Genetic Leap, Genetic Technologies, Genetron Health, Genevant Sciences, GenFleet Therapeutics, Genialis, Genmab, Genocea Biosciences, Genome and Company, Genome Diagnostics, Genome Insight, Genome Institute of Singapore, Genomic Testing Cooperative, Genomill Health, Genomoncology, Genor Biopharma, Genoscience, Genprex, GenScience Pharmaceuticals, GenScript Biotech, GenScript ProBio, Genuv, Georgetown University, George Washington University, Georgiamune, German Cancer Research Center, German Federal Ministry of Education and Research, Gestalt Diagnostics, Ghent University, Gicell, GigaMune, GI Innovation, Gilead Sciences, Ginkgo BioWorks, GlamorousAI, Glenmark Pharmaceuticals, Glenmark Pharmaceuticals S.A., GlobalBio, Global Cancer Technology, Global Coalition for Adaptive Research, Global Liver Institute, Gloria Biosciences, GlycoMantra, GlycoMimetics, GlycoNex, Glycostem Therapeutics, Glycotope Biotechnology, Glykos, Glytherix, GNS Healthcare, GO2 Foundation for Lung Cancer, GOG Foundation, Google, GO Therapeutics, Government of Hong Kong, Government of Ireland, Government of Netherlands, GPCR Therapeutics, Gracell Biotechnologies, Grail, Graviton Bioscience, Greenlight Biosciences, Greenwich LifeSciences, Grey Wolf Therapeutics, Grid Therapeutics, GRIT Biotechnology, Gritstone Bio, Groupe d'OncologieRadiothérapie Tête Et Cou, Groupe Francophone des Myélodysplasies, GSK, GT Apeiron Therapeutics, GT Biopharma, GT Medical Technologies, Guangzhou Fanen Biotechnology, Guangzhou Ruianbo Pharmaceutical Technology, Guangzhou Ruiao Biopharmaceutical Technology, Guardant Health, Guerbet, Guohong Guokang (Beijing) Health Technology Development, GV20 Therapeutics, H3 Biomedicine, Hackensack Meridian Health, Hadassah Medical Center, HaemaLogiX, Hainan Sinotau Pharmaceutical, Hairy Cell Leukemia Foundation, Halberd, HalioDx, HALO Precision Diagnostics, Hamlet Pharma, HanAll Biopharma, HanAll Pharmaceuticals, HanchorBio, Hande Sciences, Handok Pharmaceuticals, Hangzhou CNK Therapeutics, Hangzhou Zhongmei Huadong Pharmaceutical, Hanmi Pharmaceutical, HanX Biopharmaceuticals, Harbinger Health, Harbour Biomed, Harpoon Therapeutics, Harvard Medical School, Harvard T.H. Chan School of Public Health, Harvard University, HavaH Therapeutics, HAYA Therapeutics, Haystack Oncology, HCW Biologics, HDT Bio, HealthMyne, HebeCell, Hebrew University of Jerusalem, Heidelberg Pharma, Heligenics, Helio Genomics, Helio Health, Helmholtz Zentrum Munchen, Helsinn Healthcare, Helsinn Therapeutics, Hematology-Oncology Associates of Central New York, Hemogenyx, Henan Cancer Hospital, Hengenix Biotech, Hengrui Therapeutics, Henlius Biotech, Henry M. Jackson Foundation, Hera BioLabs, Heska, HiberCell, HIBio, Hibiscus BioVentures, HiFiBio, Highlight Therapeutics, Hikma Pharmaceuticals, Hillstream BioPharma, HiloProbe, HistoIndex, Hisun BioRay, HitGen, HK inno.N, HLB Therapeutics, Hoffmann La Roche, Hokkaido University, Holobeam Technologies, Hologic, Hong Kong University of Science & Technology, Hookipa Pharma, Horizon Discovery, Horizon Europe, Hospital Clinic of Barcelona, Hospital for Sick Children, Hospital of University of Strasbourg, Hoth Therapeutics, HotSpot Therapeutics, Hox Therapeutics, HTG Molecular Diagnostics, Huadong Medicine, Hualan Genetic, Hufeland Klinikum, Huma, Humanitas University, Hummingbird Bioscience, Huntsman Cancer Institute, Hutchmed, Huyabio International, HUYA Bioscience, Hyloris Pharmaceuticals, Hypospray Pharma, Hyundai Hope On Wheels, I-mab, IASO Biotherapeutics, Iaso Pharmaceuticals, Iaso Therapeutics, IBA, Ibex Medical Analytics, iBio, IBM, iCAD, Icahn School of Medicine at Mount Sinai, ICAN, IcanoMAB, Ichnos Sciences, Ichor Medical Systems, Icon, IDEAYA Biosciences, IDEOlogy Health, Idorsia, IGEA Clinical Biophysics, IGM Biosciences, Ikena Oncology, Ikonisys, Ikonopedia, Iksuda Therapeutics, Iktos, Ildong Pharmaceutical, Illumina, Imagene Labs, ImaginAb, IMBdx, Immagene, Immatics Biotechnologies, Immedica, Immix Biopharma, Immorna, Immunai, Immune-Onc Therapeutics, Immuneering, ImmuneOncia Therapeutics, ImmuneOnco Biopharmaceuticals, Immune Therapeutics, ImmuNext, Immunicom, Immunicon, Immunitas Therapeutics, ImmunityBio, ImmunoAdoptive Cell Therapy, ImmunoChina Pharmaceuticals, Immunocore, ImmunoGen, ImmunoGenesis, Immunome, Immunomedics, Immunomic Therapeutics, ImmunoPrecise Antibodies, ImmunoScape, ImmunOs Therapeutics, Immunovia, ImmuPharma, Immutep, ImmVira, IMPACT Therapeutics, Imperial College London, Imugene, IMV, Imvaq Therapeutics, In4Derm, IncellDx, Inceptor Bio, Inceptua, Incyclix Bio, Incyte, Indapta Therapeutics, Indaptus Therapeutics, Indiana University, Indica Labs, Indivumed, Industrial Centre for Artificial Intelligence Research in Digital Diagnostics, Infinimmune, InflaRx, Inform Diagnostics, Inhibikase Therapeutics, Inhibitor Therapeutics, Inhibrx, Inivata, INmune Bio, InnDura Therapeutics, InnoBation, Innoplexus, Innosuisse, Innovate BC, Innovate UK, Innovation Norway, Innovative Medicines Initiative (IMI), Innovent Biologics, Innsena, Inocras, Inovio, InProTher, Inserm, InSightec, Insilico Medicine, InSitu Biologics, InSphero, Inspirna, Instil Bio, Institut Bergonie, Institut Carnot CALYM, Institut Curie, Institute for Follicular Lymphoma Innovation, Institute for Molecular Medicine Finland, Institute for Research in Immunology and Cancer – Commercialization of Research, Institute for Systems Biology, Institute of Cancer Research, Institute of Oncology Research, Institut Gustave Roussy, Institut Paoli-Calmettes, Intas Pharmaceuticals, Integra Connect, Integral Molecular, Integrated Biosciences, Integra Therapeutics, Intellia Therapeutics, Intelligent Medical Objects, Intelliseq, Intensity Therapeutics, Intermountain Precision Genomics, International Association for the Study of Lung Cancer, International Centers for Precision Oncology Foundation, Intima Bioscience, Intonation Research Laboratories, IntraOp Medical, Invasight, Invectys, Invenio Imaging, Invenra, Inventum Genetics, inviCRO, invIOs, Invitae, InVivoScribe, InxMed, IO Biotech, iOncologi, iOnctura, Ionis Pharmaceuticals, Ionova, Iovance Biotherapeutics, IOVaxis Therapeutics, iPrime Therapeutics, iProgen Biotech, Ipsen, IQVIA, IRBM, Isofol Medical, Isologic Innovative Radiopharmaceuticals, Isotopia Molecular Imaging, Italian Association for the Study of Pancreas, iTeos Therapeutics, Iterion Therapeutics, ITM Isotopen Technologien, IUCT, Ivy Brain Tumor Center, Ixaka, Ix Therapeutics, Jackson Laboratory, Jacobio Pharmaceuticals, JAMP Pharma Group, Janssen Biotech, Janssen Pharmaceuticals, Janssen Pharmaceutica NV, Janssen Research & Development, Janux Therapeutics, Japan Agency for Medical Research and Development, Japanese Foundation for Cancer Research, Jazz Pharmaceuticals, Jefferson Healthcare, JelloX Biotech, Jemincare, Jenga Biosciences, Jenthera Therapeutics, Jerome Canady Research Institute for Advanced Biological and Technological Sciences, Jiangsu Chia Tai Tianqing Pharmaceutical, Jiangsu Hansoh Pharmaceutical, Jiangsu Hengrui Medicine, Jiangsu Hengrui Pharmaceuticals, Jiangsu Wuzhong Pharmaceutical, J Ints Bio, JMT-Bio, Jnana Therapeutics, Johannes Gutenberg University, John Hopkins University School of Medicines, Johns Hopkins University, Johnson & Johnson, Johnson & Johnson Innovation, Josep Carreras Leukaemia Research Institute, Jounce Therapeutics, Joyo Pharmatech, JSR Life Sciences, Jubilant Therapeutics, Juniper Biologics, Juno Therapeutics, Junshi Biosciences, Juntendo University, Jupiter Bioventures, Jura Bio, JW Biotechnology, JW Therapeutics, K2bio, Kahn-Sagol-Maccabi, KAHR Medical, Kaiku Health, Kainos Medicines, Kalbe Genexine Biologics, KaliVir Immunotherapeutics, Kanazawa University, Kanvas Biosciences, Kanyr Pharma, Karkinos Healthcare, Karolinska Institute, Karolinska University Hospital, Kartos Therapeutics, Karyopharm Therapeutics, Kazia Therapeutics, KDx Diagnostics, Keio Gijuku University, Kelonia Therapeutics, Kelun-Biotech Biopharmaceutical, Kephera Diagnostics, Keros Therapeutics, Keymed Biosciences, Kheiron Medical Technologies, Kiadis Pharma, Kibur Medical, Kincell Bio, Kineta, Kings College London, Kinnate Biopharma, Kiq, Kiromic Biopharma, Kissei Pharmaceutical, Kite Pharma, Kiyatec, Kleo Pharmaceuticals, Knight Therapeutics, Kobe University, Korea Drug Development Fund, Korea Institute of Radiological and Medical Sciences, Kovina Therapeutics, Krankenhaus Nordwest, Kriya Therapeutics, Kronos Bio, KSQ Therapeutics, Kumquat Biosciences, Kura Oncology, Kuva Labs, KYAN Therapeutics, Kyowa Hakko Kirin, LabConnect, LabGenius, Laboratory Corporation of America, Laboratory of Pathology, Laekna, Laevoroc Oncology, La Jolla Institute for Allergy & Immunology, LamKap Bio Group, LaNova Medicines, Lantern Pharma, Lantheus Holding, Lantheus Medical Imaging, Lassen Therapeutics, Latvian Institute of Organic Synthesis, LaunXP Biomedical, Lava Therapeutics, Lawson Health Research Institute, Leal Health, Leap Therapeutics, Lee Health, Lee Moffitt Cancer Center, Legend Biotech, LegoChem Biosciences, Lehigh Valley Health Network, Leica Biosystems, Leica Microsystems, Leidos, Leo Cancer Care, LEO Pharma, Lepu Biopharma, Les Laboratoires Servier, Leucid Bio, Leukemia & Lymphoma Society, LeukoCom, Leveragen, Lexicon Pharmaceuticals, LG Chem, LG Life Sciences, LianBio, Libera Bio, Life Magnetics, LifeMax Laboratories, LifeOmic, Life Raft Group, LifeSensors, Lifespin, Life Technologies Corporation, LIfT BioSciences, LigaChem Biosciences, Ligand Pharmaceuticals, Light Horse Therapeutics, Lightpoint Medical, Limbus AI, LimmaTech Biologics, Lindis Biotech, Lineage Cell Therapeutics, LineaRx, LinKinVax, Linnaeus Therapeutics, Lion TCR, Liquid Biosciences, Lisata Therapeutics, LiteCure Medical, LiteVax, Little Warrior Foundation, Livzon Mabpharm, Lixte Biotechnology, Lodo Therapeutics, Logomix, Longwood University, Lonza, Lotus Pharmaceuticals, Loxo Oncology, Lubrizol, Lucence, Lukas Biomedical, LumaBridge, Luminary Therapeutics, Lunaphore, Lundquist Institute, Lung Biotechnology, Lung Cancer Foundation of America, Lung Cancer Initiative, Lung Cancer Research Foundation, LUNGevity Foundation, Lunit, Lupagen, Lupin, Lurie Children's Hospital of Chicago, Lyell Immunopharma, Lynk Pharmaceuticals, Lytix Biopharma, Lyvgen Biopharma, M2Gen, M42, MaaT Pharma, MabCare Therapeutics, MAB Discovery, Mablink Bioscience, mAbsolve, Mabwell Bioscience, mAbXience, Macao Kiang Wu Hospital, Maccabi Healthcare Services, Macomics, Macrogen, Macrogenics, MagBio Genomics, MagCorp, Magenta Therapeutics, MagForce, Magic Leap, Magle Chemoswed, Magnet Biomedicine, MAIA Biotechnology, Maine Medical Center, Mainz Biomed, Manhattan BioSolutions, MapKure, Marengo Therapeutics, Maria Curie-Sklodowska University, Marker Therapeutics, Mark Foundation for Cancer Research, Mary Crowley Cancer Research Center, MASORI Therapeutic, Massachusetts General Hospital, Massachusetts Institute of Technology, Massachusetts Life Sciences Center, Mass General Brigham, Massive Bio, Mater Research, Matrix Biomed, Mauna Kea Technologies, Maverick Therapeutics, Mawi DNA Technologies, Max-Delbruck Center for Molecular Medicine, Maxcyte, Max Planck Institute for Multidisciplinary Sciences, Mayo Clinic, McGill University, McKesson, McMaster University, McQuade Center for Strategic Research and Development, MD Anderson Cancer Center, MDimune, MDS, MDxHealth, Medac, Medexus Pharmaceuticals, Medial EarlySign, MEDIAN Technologies, Medical College of Georgia, Medical College of Wisconsin, Medical Research Council, Medical University of Graz, Medical University of Innsbruck, Medical University of Vienna, Medical University South Carolina, Medicenna Therapeutics, Medicines Discovery Catapult, Medicines Patent Pool Foundation, MEDiC Life Sciences, Medidata Solutions, MediGene, MediLink Therapeutics, Medipath, MediSix Therapeutics, Medison Pharma, Medivir, Medivizor, Medolife Rx, MedPacto, Medsenic, Medshine Discovery, MEDSIR, Meharry Medical College, Meiji Seika, MEI Pharma, Meitheal Pharmaceuticals, Melanoma Research Alliance, Melax Technologies, Memorial Sloan Kettering Cancer Center, Memo Therapeutics, Menarini, Mendus, Mentice, MercachemSyncom, Merck and Co, Merck KGaA, Merck Sharpe & Dohme, Mereo BioPharma, Mersana Therapeutics, Merus, Mestag Therapeutics, Mestastop, Metabolon, Metafora Biosystems, Metagenomi, MetaSight Diagnostics, ME Therapeutics, Methodist Hospital Houston, Metis Therapeutics, MetOx Technologies, Mevion Medical Systems, MGFB, MGI Tech, Michelson Center, Michigan State University, Microba Life Sciences, Microbiotica, Micronoma, Microsoft, Microviable Therapeutics, MilliporeSigma, Miltenyi Biotec, Mimetas, MIM Software, Minaris Regenerative Medicine, MindRank AI, Minerva Biotechnologies, Minerva Imaging, MiNK Therapeutics, Minotaur Therapeutics, Mirada Medical, Mirati Therapeutics, Mirror Biologics, miR Scientific, MiRXES, Mission Bio, MITRE, Mitsubishi Tanabe Pharma, MJH Life Sciences, Moderna, Molcure, Molecular Health, Molecular Partners, Molecular Targeting Technologies, Molecular Templates, Moleculin Biotech, Molecure, MOMA Therapeutics, Mongoose Bio, Monoceros Biosystems, Monopar Therapeutics, Montai Therapeutics, Montefiore Health System, Monte Rosa Therapeutics, Moonlight Bio, MorphoSys, Mor Research Applications, Mosaic ImmunoEngineering, Mount Sinai Health System, MP Group, MPM Capital, mProbe Laboratories, MSD, MS Pharma, MThera Pharma, Multidisciplinary Association for Psychedelics Studies, Multimmune, Multiple Myeloma Research Foundation, Multitude Therapeutics, Mundipharma, Munich Technical University, Mustang Bio, MyBiotics Pharma, Myeloid Therapeutics, Mymetics, myNEO, Myovant Sciences, My Personal Therapeutics, Myriad Genetics, Myricx Bio, Mythic Therapeutics, Nagoya University Graduate School of Medicine, Nanjing King-friend Biochemical Pharmaceutical, Nanjing Leads Biolabs, Nano-X Imaging, Nanobiotix, Nanocarry Therapeutics, Nanoform, NanoMab Technology, NanoSmart Pharmaceuticals, Nanostics Precision Health, NanoString Technologies, Nanotechnology Characterization Laboratory, NaNotics, NanoTx Therapeutics, NanoVation Therapeutics, NanoView Biosciences, Nantes University, NantOmics, Napo EU, Napo Pharmaceuticals, Nascent Biotech, Natera, National Brain Tumor Society, National Cancer Care Alliance, National Cancer Center, National Cancer Center of Japan, National Cancer Centre Singapore, National Cancer Institute, National Center for Advancing Translational Sciences (NCATS), National Centre for Research and Development, National Comprehensive Cancer Network (NCCN), National Health Service, National Heart, Lung and Blood Institute, National Institute for Bioprocessing Research and Training, National Institute for Health Research (NIHR), National Institute for Public Health and the Environment, National Institute of Dental and Craniofacial Research (NIDCR), National Institute of General Medical Sciences, National Institute of Neurological Disorders and Stroke, National Institutes of Health, National Institutes of Health Clinical Center, National Organization for Rare Disorders, National Research Council of Canada, National Resilience, National Science Foundation, National University Cancer Institute, National University of Ireland, Galway (NUI Galway), Nationwide Children’s Hospital, Nautilus Biotech, Naval Medical Research Center, Naveris, Navidea Biopharmaceuticals, Navigo Proteins, Navrogen, NAYA Biosciences, NBE Therapeutics, nCage Therapeutics, NEC, NEC Bio Therapeutics, Nectin Therapeutics, NED Biosystems, Nektar Therapeutics, Nelum Pharma, NeoCura Bio-Medical Technology, Neogap Therapeutics, Neogene Therapeutics, Neogenomics, NeoImmuneTech, Neoleukin Therapeutics, Neomorph, NeOnc Technologies, NeoPharm, NeoPhore, Neoregen Biotech, Neosoma, NeoX Biotech, NeraCare, Nerviano Medical Sciences, Netherlands Cancer Institute, NetraMark, NETRIS Pharma, NeuCen BioMed, Neurix, Neurochase, Neuropore Therapies, Neutron Therapeutics, Neuvogen, NewCanna Hub, Newcastle University, NewG Lab, New Horizon Health, Newsoara Biopharma, NewStem, New Wave Ventures, New York Cancer & Blood Specialists, New York University School of Medicine, Nexcella, Nexelis, Neximmune, NextCure, Next Generation Manufacturing Canada, NEXT Oncology, NextRNA Therapeutics, NGeneBio, NGM Biopharmaceuticals, Nico, NiKang Therapeutics, Nilogen Oncosystems, Nimble Therapeutics, Ningbo NewBay Medical Technology, Niowave, Nippon Kayaku, Nippon Shinyaku, Nirogy Therapeutics, Nkarta Therapeutics, NKGen Biotech, NKMax America, Nobelpharma, Noga Therapeutics, Noile-Immune Biotech, Nona Biosciences, Nonacus, Nordic Nanovector, Nordic Society of Gynaecological Oncology, Norgine, Noria Therapeutics, Normunity, North Carolina State University, Northeastern University, Northern Biologics, Northern RNA, NorthStar Medical Radioisotopes, Northwest Biotherapeutics, Northwestern University, NorthX Biologics, Norwegian Cancer Society, Notable Labs, Nouscom, NovAccess Global, Novadiscovery, NovalGen, NovAliX, Novarad, NovaRock Biotherapeutics, Novartis, NovaScan, Novellus Biopharma, Novellus Therapeutics, Novocure, Novogene, Novo Nordisk, Noxopharm, NRG Oncology, nRichDX, NTT Data, Nuance Healthcare, Nuance Pharma, Nucleai, Nucleix, Nuclidium, NuclixBio, Numab, Nuntius Therapeutics, NuProbe, Nurix Therapeutics, Nurosene, Nuvectis Pharma, Nvidia, NX Development, NXgenPort, Nykode Therapeutics, NYU Grossman School of Medicine for Preclinical and Clinical Research, NYU Langone Medical Center, Oasmia Pharmaceutical, OBI Pharma, Oblique Therapeutics, Obsidian Therapeutics, Ocean Biomedical, Odeon Therapeutics, Odimma Therapeutics, Ohio State University, Olatec Therapeutics, Olema Oncology, Olimmune, Olink Proteomics, Olivia Newton-John Cancer Research Institute, Omega Therapeutics, Omico, OmiCure, OmniaBio, OmniSpirant, Ona Therapeutics, Oncidium Foundation, OncoAssure, OncoBay Clinical, OncoBone Ventures, OncoC4, Oncoceutics, Oncoclinicas, OncoCyte, Oncode Institute, Oncodesign, OncoDNA, Oncoheroes Biosciences, OncoHost, Oncologie, Oncology Group, Oncology Pharma, Oncology Research Information Exchange Network, Oncology Venture, Oncolytics Biotech, Oncompass Medicine, OncoMyx Therapeutics, OncoNano Medicine, Onconova Therapeutics, Oncopeptides, OncoResponse, Oncorus, OncoSec Medical, Oncoshot, Oncosyne, Oncotelic, OncoVerity, Oncovet, Oncovir, OncoX BioPharma, OncoZenge, Oncternal Therapeutics, OnCusp Therapeutics, OncXerna Therapeutics, OneOncology, OneThree Biotech, oNKo-innate, ONK Therapeutics, OnKure, OnLume Surgical, Ono Pharmaceutical, Onsite Women’s Health, Ontada, Ontario Institute for Cancer Research, Ontario Institute for Regenerative Medicine, Onward Therapeutics, Onxeo, OpenBench, OpenEye Scientific Software, Optellum, Optieum Biotechnologies, Optimeos Life Sciences, OptraHEALTH, OracleBio, Orange Grove Bio, Orano Med, OrbiMed Asia Partners, Orbit Discovery, Orca Bio, Ordaos Bio, Oregon Health Sciences University, Oregon Oncology Specialists, Oregon Therapeutics, Organon, Orgenesis, Ori Biotech, ORIC Pharmaceuticals, OrigiMed, Orion, Orionis Biosciences, Orna Therapeutics, Orsenix, Osaka University, Oscotec, OSE Immunotherapeutics, Osel, Oslo University Hospital, Ospedale Pediatrico Bambino Gesu, OSR Holdings, Ossium Health, Ostentus Therapeutics, Oswaldo Cruz Foundation (Fiocruz), Ottawa Health Research Institute, Ottawa Hospital Research Institute, Outpace Bio, Ovation, Overland ADCT BioPharma, Overland Pharmaceuticals, Owkin, Owlstone Medical, Oxford BioMedica, Oxford BioTherapeutics, Oxford Drug Design, Oxford Nanopore Technologies, Oxford Vacmedix, Oxyrane UK, Ozette Technologies, Pacific Biosciences, Pacific Cancer Care, Pacific Pediatric Neuro-Oncology Consortium, PACT Pharma, Pacylex, Paige, Palleon Pharmaceuticals, Paltown Development Foundation, Panbela Therapeutics, panCELLa, Pancreatic Cancer Action Network, Pancreatic Cancer Early Detection Consortium, Pangea Biomed, Pangu BioPharma, Panolos Bioscience, Papyrus Therapeutics, Paradigm, Parexel, Parthenon Therapeutics, Partnership for Accelerating Cancer Therapies, Partner Therapeutics, Pascal Biosciences, PathAI, Pathnova Laboratories, PathomIQ, Pathos AI, Paul Scherrer Institute, PCI Biotech, PDRadiopharma, PDS Biotechnology, Pearl Bio, PEAR Therapeutics, Penn Medicine, Penn State Cancer Institute, Pennsylvania State University, Pepscan, PeptiDream, Peptone, Peptron, Persephone Biosciences, Personal Genome Diagnostics, Personalis, PersonGen BioTherapeutics, Perspective Therapeutics, Perthera, Peter MacCallum Cancer Institute, Pfizer, Pfizer Canada, Phanes Therapeutics, PharmAbcine, PharmaEngine, PharmaEssentia, PharmaJet, PharmaLogic, PharmaMar, Pharmanovia, Pharmapark, PharmaTher, Pharmsynthez, Pharus Diagnostics, Phase Genomics, PHC, Phebra, Phenomic AI, PhenoVista Biosciences, Pheon Therapeutics, Phillips-Medisize, Philochem, Philogen, Phio Pharmaceuticals, PhoreMost, Phost’in Therapeutics, Photocure ASA, PhotonPharma, Physiomics, Phytronix Technologies, Pieces Technologies, Pierian, PierianDx, Pieris Pharmaceuticals, Pierre Fabre, Pillar Biosciences, PineTree Therapeutics, Pint Pharma, Pionyr Immunotherapeutics, Piramal, PixCell Medical, Planet Innovation, Plan France Relance, Planmed, PlantForm, PlantPraxis Biotecnologia, Pleco Therapeutics, Plexxikon, Pluristyx, Plus Therapeutics, PlusVitech, PMV Pharma, PoC Capital, Point32Health, POINT Biopharma, Polarean Imaging, Polaris Group, PolarisQB, Polifarma, Polyphor, PolyPid, Pompeu Fabra University, Portage Biotech, Porton Pharma Solutions, Poseida Therapeutics, PRA Health Sciences, Precipio Diagnostics, PreciseDx, Precision-Panc, Precision BioSciences, Precision for Medicine, Precision Health Informatics, Precision Molecular, Precision NanoSystems, Precision Pathology Services, Predicine, Predictive Oncology, Predictive Technology Group, Pregene Biopharma, Prelude Therapeutics, Premier Inc, PreMIT, Prenetics, Presage Biosciences, Prescient Medical, Pressure BioSciences, Prestige BioPharma, Previse, Prime Medicine, Primordial Genetics, Princess Margaret Hospital, Princeton University, Prisma Health, PRISM BioLab, Privo Technologies, ProBioGen, Procare Health, ProEn Therapeutics, ProfoundBio, Progenetics, Progenics Pharmaceuticals, PrognomIQ, Prokarium, Prolium Bioscience, ProMab Biotechnologies, Promega, Propanc Biopharma, ProPath, Propella Therapeutics, Prophase Labs, ProQinase, Proscia, Prostate Cancer Clinical Trials Consortium, Protean BioDiagnostics, ProteinTech, ProteoMediX, ProteoNic, Proteros biostructures, Protocol First, ProTom International, Proton Therapy, Providence Cancer Institute, Providence Therapeutics, Proxygen, PSI CRO, PsiVac, PT Elion Medika, PT Etana Biotechnologies, Puerto Rico Government, Pulmatrix, Puma Biotechnology, Purdue Research Foundation, Purdue University, Pure Biologics, PureForm Global, Pure MHC, PureTech Health, Purple Biotech, Pyramid Biosciences, Pyxis Oncology, Q BioMed, QBiotics, QDX, QED Therapeutics, QIAGEN, Qilu Pharmaceutical, Qlarity Imaging, QT Imaging, Quadira Biosciences, Quadri Pharmaceuticals, Qualigen, Quantgene, Quantum Leap Health Care Collaborative, Qubit Pharmaceuticals, Quebec Consortium for Drug Discovery, Quebec Heart and Lung Institute, Queen Mary University of London, Queensland Institute of Medical Research (QIMR), Queensland University of Technology, Queens University Belfast, Quercis Pharma, Quest Diagnostics, Qure Healthcare, Qurient, R-Pharm, Race Oncology, Radboud University Nijmegen, Radiance Biopharma, Radiomedix, Radionetics Oncology, Radiopharm Theranostics, Radius Health, Rady Children's Institute for Genomic Medicine, Rafael Pharmaceuticals, Rain Oncology, Rakovina Therapeutics, Rakuten Medical, Rambam Medical Center, Ranok Therapeutics, Rappta Therapeutics, Rarecells, Ratio Therapeutics, RayBiotech, RaySearch Laboratories, RayzeBio, RCK, Realm IDx, Recombinetics, Recro Pharma, Recurrent Respiratory Papillomatosis Foundation, Recursion, RedHill Biopharma, Redwood Bioscience, Redx Pharma, RefleXion Medical, Refuge Biotechnologies, Regen BioPharma, Regeneron Pharmaceuticals, Regional Cancer Institute of Montpellier, Reglagene, Regnum, Regor Therapeutics, Relay Therapeutics, RemeGen, Remix Therapeutics, Renato Dulbecco Foundation, RenovoRx, Renown Institute for Health Innovation, Repare Therapeutics, Repertoire Immune Medicines, Replay, Replicate Bioscience, Replimune, ReproCell, Reset Pharmaceuticals, Res Nova Bio, Resolution Bioscience, RevealDx, Reveal Genomics, ReviR Therapeutics, Revitope Oncology, Revive Therapeutics, Revolution Medicines, Rgene, Rgenta Therapeutics, Rhizen Pharmaceuticals, Ribon Therapeutics, Richard Wolf Medical Instruments, Rigel Pharmaceuticals, RIKEN Research Institute, Rising Tide Foundation, Rivaara Immune, Roche, Roche Diagnostics, Rockefeller University, Rocket VR Health, Roivant Sciences, Rondo Therapeutics, RoosterBio, Roswell Park Cancer Institute, Royal Marsden Hospital, Royal Philips Electronics, Rubix LS, RubrYc Therapeutics, Rutgers Cancer Institute of New Jersey, Rutgers University, Rxilient Biotech, Ryvu Therapeutics, Rznomics, S2 Genomics, Saccharo, SAGA Diagnostics, Saga University, Saint-Gobain Life Sciences, Sairopa, Saladax Biomedical, Salarius Pharmaceuticals, Salk Institute, Samsung Bioepis, Samsung Biologics, Samyang Biopharmaceuticals, Sana Biotechnology, Sandoz, Sanford Burnham Institute, Sangamo Therapeutics, San Gerardo Hospital, Sanofi, San Raffaele Hospital, SanReno Therapeutics, Sant Joan de Déu-Barcelona Children’s Hospital, Sanwa Kagaku Kenkyusho, Sapien Biosciences, Sapience Therapeutics, Sapphire Biotech, Sapu Bioscience, Sarah Cannon Research Institute, Sarcoma Oncology Center, Sartorius Stedim Biotech, Satisfai Health, SATT Nord, Scailyte, Scancell, Scandion Oncology, Scenic Biotech, Schrodinger, SciBase, SciClone Pharmaceuticals, Science 37, Scintomics, Scopus BioPharma, Scorpion Therapeutics, Screenpoint Medical, Scribe Therapeutics, Scripps Research Institute, Seagen, Seattle Children's Hospital, Seattle Children's Therapeutics, Seattle Genetics, Sebela Pharmaceuticals, Sebia, Secarna Pharmaceuticals, Secura Bio, Seed Therapeutics, SeekIn, Seibersdorf Laboratories, Seismic Bio, Selexis, SELLAS Life Sciences Group, Selvita, Sema4, Seneca Therapeutics, SEngine Precision Medicine, Sensei Biotherapeutics, Senti Biosciences, Sentinel Diagnostics, Sentinel Oncology, Seoul National University, SequMed, SeraNovo, Sermonix Pharmaceutical, Serotiny, Sesen Bio, Seven and Eight Biopharmaceuticals, Seven Bridges Genomics, SevenScore Pharmaceuticals, SFJ Pharmaceuticals, Shanghai Affinity Biopharmaceutical, Shanghai Pharmaceutical, Shanghai Pharmaceuticals Holdings, Sharp HealthCare, Shasqi, Sheba Medical Center, Shenogen Pharma, Shenzhen Chipscreen Biosciences, Shepherd Therapeutics, Sherlock Biosciences, Shimadzu, SHINE Technologies, Shinshu University, Shoreline Biosciences, Shorla Oncology, Showa Denko, Shuttle Pharmaceuticals, Sibylla Biotech, Sidney Kimmel Cancer Center, Siemens Healthineers, Sierra Oncology, SIGA Technologies, Signet Therapeutics, Signify Health, Silexion Therapeutics, SillaJen, SimBioSys, Simcere Pharmaceuticals, Simcha Therapeutics, Similis Bio, Simnova, Simsen Diagnostics, Simulations Plus, Singlera Genomics, Singleron Biotechnologies, Singular Genomics Systems, Sino-American Cancer Foundation, Sinorda Biomedicine, Siren Biotechnology, Sirion Biotech, Sirnaomics, Sirona Dx, Sirona Medical, Sirtex Medical, SiSaf, Skane University Hospital, SK Biopharmaceuticals, Skin and Cancer Institute, Skyhawk Therapeutics, Skyline Diagnostics, SkylineDX, Skysong Innovations, Smart Immune, Smerud Medical Research, Smiths Medical, SN BioScience, Solaris, Solasia Pharma, Soligenix, Solis Mammography, Solve Therapeutics, SomaLogic, SonALAsense, Sonnet BioTherapeutics, Sonrai Analytics, Sony, Sookmyung Women's University, SOPHiA Genetics, Sorrento Therapeutics, Sorse Technology, Sosei Heptares, SOTERIA Precision Medicine Foundation, SOTIO, Southern Oncology Specialists, Spanios, Spanish Lung Cancer Group, Spanish National Cancer Research Centre, Spanish National Research Council, Spanish State Research Agency, SparX Biopharmaceutical, Specialised Therapeutics, SpectronRx, Spectrum Pharmaceuticals, Spectrum Solutions, Spesana, SpringWorks Therapeutics, Sprint Biosciences, St. Baldrick's Foundation, St. Jude Children's Research Hospital, STADA Arzneimittel, Stand Up To Cancer, Stanford University, Stanford University School of Medicine, Starpharma, Starton Therapeutics, Statera Biopharma, STC Biologics, STCube, Stella Diagnostics, Stemline Therapeutics, Stem of Hope, StemoniX, Step Pharma, SteroTherapeutics, Stimunity, Stony Brook University, Storm Therapeutics, Strand Therapeutics, Strata Oncology, Stupid Strong Charitable Foundation, SUDA Pharmaceuticals, Sumitomo Dainippon Pharma, Summit Therapeutics, Summus, Sunnybrook Research Institute, Sun Pharma Advanced Research Company, Sun Pharmaceutical, SunRock Biopharma, Sunshine Biopharma, Sunstone Therapies, SUNY Upstate Medical University, Surface Oncology, Susan G. Komen for the Cure, Sutro Biopharma, Suzhou GenHouse, Suzhou Porton Advanced Solutions, Suzhou Puhe BioPharma, Suzhou Runxin Biotechnology, Swedish Orphan Biovitrum, Swiss Institute of Bioinformatics (SIB), Swiss Pharmaceutical, Syapse, Syena, Symbasis, Synaffix, Syncromune, Syndax Pharmaceuticals, SynDevRx, Syneos Health, Syngene, Synthekine, Syracuse Biopharma, Syros Pharmaceuticals, Sysmex, Sysmex Inostics, Systems Oncology, Systimmune, T-Cure Bioscience, Tabula Rasa HealthCare, Tachyon Therapeutics, TAE Life Sciences, Tagomics, Taiba, TaiGen Biotechnology, Taiho, Takeda Oncology, Takeda Pharmaceutical, Takeda Ventures, Talem Therapeutics, Tallac Therapeutics, Talus Bioscience, Tampa General Hospital Cancer Institute, Tango Therapeutics, Targovax, Tarveda Therapeutics, Tasly Pharmaceuticals, Tavotek Biotherapeutics, Tavros Therapeutics, TC BioPharm, TCR2 Therapeutics, TeamConnor Childhood Cancer Foundation, Techcyte, Tegmine Therapeutics, Teijin, Tel Aviv University, Telix Pharmaceuticals, Tella, Tempest Therapeutics, Tempus, TeneoBio, Tennessee Oncology, Tentarix Biotherapeutics, Teon Therapeutics, TeraRecon, Terns Pharmaceuticals, Terray Therapeutics, TerSera Therapeutics, Terumo, Terumo Blood and Cell Technologies, Tesis Biosciences, Tessa Therapeutics, Teva Pharmaceutical Industries, Texas A&M University, Texas Oncology, Texcell, TFC Therapeutics, TGen Drug Development, Tharimmune, The Jackson Laboratory, The Nemours/Alfred I duPont Hospital for Children, The New York Stem Cell Foundation, The Parker Institute For Cancer Immunotherapy, Therabest, Theragen, Theragent, Theragnostics, Theralink Technologies, TheraPanacea, Therapeutic Solutions International, Therapharm, Therapixel, Theratechnologies, Theriva Biologics, Thermo Fisher Scientific, Theryq, Theseus Pharmaceuticals, The Technical University Of Munich, ThinkCyte, ThinkingNodeLife, Thomas Jefferson University, Tigerlily Foundation, TILT Biotherapeutics, Tiziana Life Sciences, Todos Medical, Tolero Pharmaceuticals, Tor Vergata University Hospital, Toshiba, Totient, Totus Medicines, Touchlight, Tracer Biotechnologies, TRACON Pharmaceuticals, Trans-Hit Bio, Transcenta, TransCode Therapeutics, Transgene, Translational Drug Development, Translational Genomics Research Institute, TransThera, Traverse Biosciences, Treadwell Therapeutics, TreeFrog Therapeutics, Treehill Partners, Treventis, TRIANA Biomedicines, Trigone Pharma, TRIGR Therapeutics, Trinity College Dublin, Trio Pharmaceuticals, TriSalus Life Sciences, TRIUMF, Triumvira Immunologics, TRT Innovations, Trutino Biosciences, TScan Therapeutics, TTC, Tubulis, TuHURA Biopharma, TuHURA Biosciences, TumorGen, TumorGenesis, Turbine, Turn Biotechnologies, Turning Point Therapeutics, Turnstone Biologics, Tvardi Therapeutics, TwinStrand Biosciences, Twinstrand Therapeutics, Twist Bioscience, TYG Oncology, Tyligand Bioscience, Tyme Technologies, Ubiquigent, UbiVac, Ubix Therapeutics, U CAN-CER VIVE Foundation, UCB, UK Government, Ultima Genomics, Ultivue, Umoja Biopharma, Unilabs, Uni Targeting Research, United Immunity, United Therapeutics, Univeristy of Durham, Universal Cells, Universal DX, University College London, University Gottingen, University Health Network, University Hospital Magdeburg, University Hospitals Case Medical Center, University Libre of Brussels, University Medical Center Utrecht, University of Alabama at Birmingham, University of Antwerp, University of Arkansas, University of Augsburg, University of Barcelona, University of Basel, University of Bern, University of Birmingham, University of Bordeaux I, University of British Columbia, University of Calgary, University of California, Davis, University of California, San Diego, University of California Berkeley, University of California Irvine, University of California Los Angeles, University of California Riverside, University of California San Francisco, University of California Santa Barbara, University of Cambridge, University of Chicago, University of Cincinnati, University of Colorado, University of Copenhagen, University of Dundee, University of Edinburgh, University of Florida, University of Granada, University of Heidelberg, University of Illinois, University of Illinois Urbana-Champaign, University of Iowa, University of Jaen, University of Kansas, University of Kentucky, University of Lausanne, University of Leeds, University of Leipzig, University of Louisville, University of Manchester, University of Marburg, University of Maryland, University of Maryland Baltimore, University of Massachusetts, University of Miami, University of Michigan, University of Milano-Bicocca, University of Minnesota, University of Missouri, University of Montreal, University of Newcastle, University of New Mexico, University of New South Wales, University of North Carolina, University of Oxford, University of Pennsylvania, University of Pittsburgh, University of Quebec, University of Queensland, University of Rochester, University of Rochester Medical Center, University of Sheffield, University of Southampton, University of South Australia, University of South Carolina, University of Sydney, University of Texas, University of Texas Health SCience Center at San Antonio, University of Texas Southwestern Medical Center, University of Tubingen, University of Tulsa, University of Utah, University of Virginia, University of Washington, University of West Indies, University of Wisconsin, University of Wisconsin Carbone Cancer Center (UWCCC), University of Wollongong, University of Wurzburg, University of Zurich, Unnatural Products, Unravel Biosciences, Unum Therapeutics, UroGen Pharma, UroPartners, UroViu, US Government, US Medical Innovations, US Oncology, US Oncology Research, US WorldMeds, UT Southwestern Medical Center, Vaccibody, Vaccinex, Valence Discovery, Valeo Pharma, Vall d’Hebron Research Institute, Valo Therapeutics, Vanderbilt University, Vannie E. Cook Jr. Children’s Cancer Clinic, Varian Medical Systems, Vaxalto Biotherapeutics, VBI Vaccines, Vector Pharma FZCO, Vectura, Vela Diagnostics, VelaVigo, Veracyte, Verastem, Veraxa Biotech, Verily, VerImmune, VeriSIM Life, Verismo Therapeutics, Verity Pharmaceuticals, Vernalis, Verrica Pharmaceuticals, Verseau Therapeutics, Versiti Blood Research Institute, Veru, VIB, Vibliome Therapeutics, Vida Diagnostics, Vidence, VieCure, ViennaLab Diagnostics, Viewpoint Molecular Targeting, ViewRay, Vignette Bio, Vincera Pharma, Vincere Cancer Center, Vinnova, Vipergen, Vir Biotechnology, Virginia Commonwealth University, Virginia Polytechnic Institute and State University, Virogen, Visiopharm, Vitanova Biomedical, Vittoria Biotherapeutics, Viva Biotech, Viventia Biotech, Vividion Therapeutics, vivoPharm, Volastra Therapeutics, VolitionRX, Volpara Health Technologies, Volpara Solutions, Voltron Therapeutics, Voluntis, Vor Biopharma, Voronoi, Vuja De Sciences, Vuzix, Vyant Bio, VyGen-Bio, VYNE Therapeutics, Vyriad, Vysioneer, Wake Forest University, Wake Forest University Baptist Medical Center, Walgreens, Wanchunbulin, Warpnine, Waseda University, Washington University in St Louis, Watchmaker Genomics, Weihai Weigao Medical Devices, Weill Cornell Medical College, Weizmann Institute, WellDyne, Wellmarker Bio, Welton Pharma, Werewolf Therapeutics, West German Study Group, Whitman-Walker Institute, Wigen Biomedicine, Wilmot Cancer Institute, Windber Research Institute, WindMIL Therapeutics, Windsong Radiology, Wisconsin Alumni Research Foundation, Wiseman Cancer Research Foundation, Wonkwang University, Worldwide Clinical Trials, WPD Pharmaceuticals, WUGEN, Wuxi Apptec Laboratory Services, WuXi Biologics, Wuxi Shuangliang Biotechnology, Wuxi STA, WuXi XDC, WY Biotech, Wyss Institute, XBiotech, Xcell Biosciences, xCures, Xencor, Xenetic Biosciences, Xiamen Biotime Biotechnology, Xilio Therapeutics, Xilis, Ximbio, XNK Therapeutics, Xoma, XtalPi, Xuanzhu Biopharma, Xylyx Bio, Xyphos Biosciences, Y-Biologics, Y-mAbs Therapeutics, Yale Cancer Center, Yale School of Medicine, Yale University, Yangtze River Pharmaceutical Group, Yatiri Bio, Yeda Research and Development Company, Yemaachi Biotech, Yingli Pharma, Yisheng Biopharma, Yissum Research Development, Ymir Genomics, Ymmunobio, Yufan Biotechnologies, Yuhan Corporation, YUMAB, Zai Lab, ZAI Laboratory, Zealand University Hospital, Zelgen, Zelluna Immunotherapy, Zenith Epigenetics, Zentalis Pharmaceuticals, Zephyr AI, ZERO Childhood Cancer, Zetagen Therapeutics, Zhejiang Doer Biotechnology, Zion Pharmaceuticals, zPREDICTA, Zydus Cadila, Zymeworks, ZYUS Life Sciences

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.